171 related articles for article (PubMed ID: 23974649)
1. [Not all drugs are the same].
Weilemann LS
Med Klin Intensivmed Notfmed; 2013 Sep; 108(6):484-90. PubMed ID: 23974649
[TBL] [Abstract][Full Text] [Related]
2. Synthetic legal intoxicating drugs: the emerging 'incense' and 'bath salt' phenomenon.
Jerry J; Collins G; Streem D
Cleve Clin J Med; 2012 Apr; 79(4):258-64. PubMed ID: 22473725
[TBL] [Abstract][Full Text] [Related]
3. [Increased abuse of the Internet drug MDPV in Västmanland. Severe cases of poisoning have given health care major problems].
Lindeman E; Hultén P; Ström S; Enlund M; Al-Saffar Y; Helander A
Lakartidningen; 2012 Oct 24-Nov 6; 109(43-44):1954-7. PubMed ID: 23198339
[No Abstract] [Full Text] [Related]
4. Bath salt abuse: new designer drug keeps EMS crews busy nationwide.
Nevin J
JEMS; 2011 Aug; 36(8):58-60. PubMed ID: 21819904
[No Abstract] [Full Text] [Related]
5. "Legal highs"--toxicity in the clinical and medico-legal aspect as exemplified by suicide with bk-MBDB administration.
Rojek S; Kłys M; Strona M; Maciów M; Kula K
Forensic Sci Int; 2012 Oct; 222(1-3):e1-6. PubMed ID: 22648055
[TBL] [Abstract][Full Text] [Related]
6. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
[TBL] [Abstract][Full Text] [Related]
7. Synthetic cannabinoid poisoning: A growing health concern.
Phillips J; Lim F; Hsu R
Nursing; 2016 Nov; 46(11):34-41. PubMed ID: 27673323
[No Abstract] [Full Text] [Related]
8. "Legal highs" - new players in the old drama.
Zawilska JB
Curr Drug Abuse Rev; 2011 Jun; 4(2):122-30. PubMed ID: 21711229
[TBL] [Abstract][Full Text] [Related]
9. Cross-reactivity of commercial immunoassays for screening of new amphetamine designer drugs. A review.
Nieddu M; Baralla E; Pasciu V; Rimoli MG; Boatto G
J Pharm Biomed Anal; 2022 Sep; 218():114868. PubMed ID: 35688007
[TBL] [Abstract][Full Text] [Related]
10. Synthetic drugs of abuse.
Tamama K
Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850
[TBL] [Abstract][Full Text] [Related]
11. The role of illicit, licit, and designer drugs in the traffic in Hungary.
Institóris L; Hidvégi E; Dobos A; Sija É; Kereszty ÉM; Tajti LB; Somogyi GP; Varga T
Forensic Sci Int; 2017 Jun; 275():234-241. PubMed ID: 28412575
[TBL] [Abstract][Full Text] [Related]
12. The evolving high: new designer drugs of abuse.
Pourmand A; Armstrong P; Mazer-Amirshahi M; Shokoohi H
Hum Exp Toxicol; 2014 Oct; 33(10):993-9. PubMed ID: 24501103
[TBL] [Abstract][Full Text] [Related]
13. Khat and synthetic cathinones: a review.
Valente MJ; Guedes de Pinho P; de Lourdes Bastos M; Carvalho F; Carvalho M
Arch Toxicol; 2014 Jan; 88(1):15-45. PubMed ID: 24317389
[TBL] [Abstract][Full Text] [Related]
14. [Synthetic cannabinoids--the new "legal high" drugs].
Berkovitz R; Arieli M; Marom E
Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277
[TBL] [Abstract][Full Text] [Related]
15. [New psychoactive substances and their prevalence in the Czech Republic].
Mravčík V; Běláčková V; Grohmannová K; Zábranský T
Cas Lek Cesk; 2015; 154(5):216-21. PubMed ID: 26612328
[TBL] [Abstract][Full Text] [Related]
16. The risk of emerging new psychoactive substances: The first fatal 3-MeO-PCP intoxication in The Netherlands.
de Jong LAA; Olyslager EJH; Duijst WLJM
J Forensic Leg Med; 2019 Jul; 65():101-104. PubMed ID: 31129558
[TBL] [Abstract][Full Text] [Related]
17. The synthetic opioid epidemic and the need for mental health support for first responders who intervene in overdose cases.
Jozaghi E; Maynard R; Dadakhah-Chimeh Z; Yake K; Blyth S
Can J Public Health; 2018 Apr; 109(2):231-232. PubMed ID: 29981029
[No Abstract] [Full Text] [Related]
18. Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A case series and review of the literature.
Armenian P; Darracq M; Gevorkyan J; Clark S; Kaye B; Brandehoff NP
Neuropharmacology; 2018 May; 134(Pt A):82-91. PubMed ID: 29037744
[TBL] [Abstract][Full Text] [Related]
19. [Psychiatric and addictologic complications of new synthetic products].
Karila L; Benyamina A
Rev Prat; 2018 Jun; 68(6):676-679. PubMed ID: 30869264
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity of designer drugs, including cathinone derivatives, in commercial enzyme-linked immunosorbent assays.
Swortwood MJ; Hearn WL; DeCaprio AP
Drug Test Anal; 2014; 6(7-8):716-27. PubMed ID: 23677923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
